SCHEMBL4601185

SCHEMBL4601185

COc1cc(-c2ccc(OC3CCCC3)c(C(=O)O)c2)cc(OC)c1OC

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 12/20 0.64
PDE4B Q07343 10/20 0.64
PDE4C Q08493 10/20 0.64
PDE4D Q08499 10/20 0.64
KMT2A Q03164 1/20 0.53
SYK P43405 2/20 0.48
POLB P06746 1/20 0.47
FFAR4 Q5NUL3 1/20 0.46
FPR2 P25090 1/20 0.46
KDM4E B2RXH2 1/20 0.45
APAF1 O14727 1/20 0.45
RECQL P46063 1/20 0.45
CASP6 P55212 1/20 0.45
CACNA1B Q00975 1/20 0.45
APBA1 Q02410 1/20 0.45
MCL1 Q07820 1/20 0.45
CASP8 Q14790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600365 0.91 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL4600716 0.86 PDE4D (0.59) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL4601471 0.85 PDE4D (0.60) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL8466183 0.85 PDE4A (0.74) PDE4APDE4BPDE4CPDE4DPOLB
SCHEMBL4602843 0.84 CFD (0.56) KMT2AKDM4EAPAF1RECQLCASP6
SCHEMBL4602161 0.81 PDE4D (0.62) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL8465687 0.81 PDE4A (0.68) PDE4APDE4BPDE4CPDE4DPOLB
SCHEMBL4601485 0.79 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL7444846 0.78 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPOLB
SCHEMBL4601903 0.78 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PDE4A 1576/4885PDE4B 1807/4885PDE4C 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.